| Literature DB >> 34975524 |
Cristina Elena Savencu1, Adina Linţa2,3, Gianina Farcaş2,3, Anca Mihaela Bînă2,3, Octavian Marius Creţu4,5, Daniel Claudiu Maliţa6, Danina Mirela Muntean2,3, Adrian Sturza2,3.
Abstract
Caloric restriction (CR) and intermittent fasting (IF) are strategies aimed to promote health beneficial effects by interfering with several mechanisms responsible for cardiovascular diseases. Both dietary approaches decrease body weight, insulin resistance, blood pressure, lipids, and inflammatory status. All these favorable effects are the result of several metabolic adjustments, which have been addressed in this review, i.e., the improvement of mitochondrial biogenesis, the reduction of reactive oxygen species (ROS) production, and the improvement of cardiac and vascular function. CR and IF are able to modulate mitochondrial function via interference with dynamics (i.e., fusion and fission), respiration, and related oxidative stress. In the cardiovascular system, both dietary interventions are able to improve endothelium-dependent relaxation, reduce cardiac hypertrophy, and activate antiapoptotic signaling cascades. Further clinical studies are required to assess the long-term safety in the clinical setting.Entities:
Keywords: caloric restriction; cardiovascular disease; endothelial dysfunction; intermittent fasting; mitochondrial function
Year: 2021 PMID: 34975524 PMCID: PMC8716834 DOI: 10.3389/fphys.2021.768383
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
The main effects of caloric restriction (CR) dietary intervention on mitochondrial function, endothelial dysfunction, and cardiovascular parameters.
|
|
|
|
|
|---|---|---|---|
| Sohal et al., | Mitochondrial respiration | Reduction of mitochondrial state 4 or resting respiratory rate | Animal model (9, 16 and 23 months-old C57BL/6NNia mice, 40% CR for 1 month) |
| Gabbita et al., | Mitochondrial respiration | Limitation of the oxy-radical production | Animal model (Brown Norway rats, 40% CR, for 47 months) |
| Gredilla et al., | Mitochondrial respiration | Modulation of complex I; reduced oxygen radicals per unit electron flow in the respiratory chain | Animal model (8 weeks-old Wistar rats, 40% CR for 6 weeks or 1 year) |
| Nisoli et al., | Mitochondrial respiration | Increased ATP concentrations in white adipose tissue | Animal model (8-weeks-old wild type and eNOS null mutant eNOS−/− mice, alternate day fasting for 3 and 12 months) |
| Shinmura et al., | Mitochondrial respiration | Preservation of state 3 respiration and increasing of respiratory control index in the presence of pyruvate/malate in ischemic-reperfused heart | Animal model (26-week-old Fischer 344 rats, 10% CR for 2 weeks, followed by 40% CR for 24 weeks) |
| Serna et al., | Mitochondrial respiration | Lower maximal respiratory rates in heart and a reduced rate of hydrogen peroxide release | Animal model (12 weeks-old Sprague-Dawley rats, 2 weeks adaptation, followed by 40% CR for 6 months) |
| Lambert et al., | Mitochondrial respiration | Increased state 4 mitochondrial respiration rate in brown adipose tissue | Animal model (60 days-old Brown Norway rats, 50% CR for 4.5 months or 17 months) |
| Nisoli et al., | Dynamics (Fusion/Fission) | Increased expression of mitofusin (MFN) 1 and 2 proteins in animals subjected to CR | Animal model (8-week-old wild type and eNOS null mutant eNOS−/− mice, alternate day fasting for 3 and 12 months) |
| Khraiwesh et al., | Dynamics (Fusion/Fission) | Increased expression of mitochondrial fission proteins (FIS1 and DRP1) in animals subjected to CR | Animal model (10 week-old C57BL/6 mice, 40% CR for 6 months) |
| Colom et al., | ROS production | Reduction of maximal H2O2 production of heart mitochondrial complexes I and III (values from females were lower compared to males) | Animal model (15-month-old Wistar rats, 40% CR for 3 months) |
| Sohal et al., | ROS production | The rates of mitochondrial superoxide and hydrogen peroxide generation increased with age and are higher in the | Animal model (9, 16 and 23 months-old C57BL/6NNia mice, 40% CR for 1 month) |
| López-Torres et al., | ROS production | Long-term CR decreased the rate of mitochondrial H2O2 generation (by 45%) and lowered oxidative damage to mtDNA (by 30%) | Animal model (12 months-old Wistar rats, 40% CR for 12 months) |
| Barros et al., | ROS production | H2O2 release/O2 consumption ratios in yeasts grown in 2% glucose were significantly higher than those of CR mitochondria | Saccharomyces cerevisiae yeast cells (cultured in medium containing 0.5 or 2% glucose) |
| Nisoli et al., | ROS production | Increased the expression of eNOS with higher concentrations of cGMP in white adipose tissue and in several other tissues | Animal model (8-week-old wild type and eNOS null mutant eNOS−/− mice, alternate day fasting for 3 or 12 months) |
| Kobara et al., | ROS production | Reduced NADPH oxidase activity and mitochondrial ROS production; Increased antioxidant systems—myocardial glutathione peroxidase and superoxide dismutase | Animal model (6 weeks-old c57BL6 mice, 40% CR for 4 weeks) |
| David et al., | ROS production | Reduction of H2O2 generation and protein sulfhydryl oxidation in the setting of isoproterenol-induced hypertrophy | Animal model (6 weeks-old Swiss mice, 40% CR for 3 weeks) |
| Waldman et al., | ROS production | Reduction of MDA levels (malondialdehyde) in the serum and increased the level of PGC-1α protein | Animal model (wild type or db/db mice 12–14 weeks old, 2 weeks 10% CR, followed by 2 weeks of 35% CR) |
| Shinmura et al., | ROS production | Reduction of the maximal H2O2 production | Animal model (26 week-old Fischer 344 rats, 40% CR for 6 months) |
| Chen et al., | ROS production | Reduction of H2O2 production from Complex I and III | Animal model (14 weeks old C57BL/6 mice, 40% CR for 1 month) |
| Judge et al., | ROS production | Increase the activity of mitochondrial superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities | Animal model (14 weeks old male Fischer 344 rats, 1 week 10% CR, 1 week 25% CR and 40% CR for 2 months) |
| Colom et al., | ROS production | Decreased heart mitochondrial H2O2 generation | Animal model (15-month-old male and female Wistar rats, 40% CR for 3 months) |
| Niemann et al., | ROS production | Improvement of mitochondrial function with lower oxidative damage. | Animal model (6 and 24 month-old Sprague–Dawley rats, 40% CR for 6 months) |
| Qiu et al., | ROS production | Protective effects of CR on oxidative stress are diminished in mice lacking SIRT3 | Animal model (6 months-old SIRT−/− mice, 30% CR for 6 months) |
| Facchini et al., | Blood pressure, lipid profile, HOMA index | CR decreased blood pressure, total cholesterol and LDL-cholesterol and the 10-yr risk of CVD-disease was reduced by 30%; homeostasis model assessment of insulin resistance (HOMA-IR) decreased during weight loss in the CR group. | Human study (3 weeks of CR (reduction with 500 kcal/day from basal energy expenditure) and high-intensity exercise training) |
| Waldman et al., | Blood pressure, lipid profile, cardiac fibrosis and hypertrophy | CR attenuated the angiotensin 2-induced hypertension in diabetic mice, improved lipid, reduced cardiac fibrosis and leukocyte infiltration, decreased genes related to cardiac remodeling | Animal model (12–14 weeks old wild type or db/db mice, 2 weeks 10% CR, followed by 35% CR for 2 weeks) |
| Deus et al., | Heart contractility | Severe CR resulted in a 50% decrease in body weight, impaired SERCA2a activity and heart contractility | Animal model (60-day-old Wistar-Kyoto rats, 50% CR for 90 days) |
| Finckenberg et al., | Cardiac fibrosis and hypertrophy | Reduction of angiotensin II-induced cardiomyocyte hypertrophy, vascular inflammation, cardiac damage and fibrosis, cardiomyocyte apoptosis, and cardiac atrial natriuretic peptide mRNA overexpression | Animal model (4-week-old double transgenic rats and age-matched normotensive Sprague-Dawley rats, 40% CR for 1 month) |
| Palee et al., | Body weight, lipid profile, blood pressure | Decrease in body weight and visceral fat deposition, decreased of plasma cholesterol levels, increased insulin sensitivity and decrease of BP | Animal model (6 months of 40% CR in high-fat-diet obese rats) |
| Fontana et al., | Lipid profile, blood glucose, blood pressure | Improvement of lipid profile, fasting glucose and insulin, normalization of BP and lower carotid artery IMT | Human study (individuals who have been practicing CR for periods from 3 to 15 years) |
| Niemann et al., | Cardiac hypertrophy | Reduction of cardiomyocyte hypertrophy and of natriuretic peptides BNP/ANP, of pro-apoptotic Bcl-xS/Bcl-xL | Animal model (6 months-old Sprague–Dawley rats, 40% CR for 6 months) |
| Almeida et al., | Vascular relaxation (contractility and endothelial dependent relaxation) | Severe CR in rats (for 2 weeks) was responsible for endothelial dysfunction in mesenteric arteries and for ischemia–reperfusion-induced arrhythmias and cardiac pathology | Animal model (4 months-old Fischer rats, 60% CR for 2 weeks) |
| Zanetti et al., | Vascular relaxation (endothelial dependent relaxation) and NOS isoforms level | Improvement of endothelium-dependent vasorelaxation, increase in eNOS level and decrease of iNOS (study in aged rats) | Animal model (6 and 24 months-old Fischer 344 rats, 26% CR for 3 weeks) |
| Ketonen et al., | Vascular relaxation and ROS production | Reverse of high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice | Animal model (3–4 weeks-old C57Bl/6 mice with induced obesity—high fat diet for 150 days, followed by 30% CR for 50 days) |
| Sasaki et al., | Vascular relaxation (evaluated by brachial artery flow mediated dilation) | Improvement of endothelium-dependent vasodilation in obese patients with essential hypertension | Human study (obese patients with essential hypertension before and after 2 weeks on a low-calorie diet–800 kcal/day) |
| Rippe et al., | Carotid artery endothelium-dependent dilation, ROS production | Short-time CR reverse of vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress (decrease of NADPH oxidase-related ROS production) | Animal model (young–5–8 months, and older–28–30 months, B6D2F1 mice, 30% CR for 8 weeks) |
| Donato et al., | Pulse wave velocity (PWV, arterial stiffness), carotid artery wall thickness, endothelium-dependent relaxation, ROS production | Long CR reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of aged mice | Animal model (young–5–7 months, and older–30–31 months, B6D2F1 mice, 40% CR life-long) |
The main effects of intermittent fasting (IF) dietary intervention on mitochondrial function, endothelial dysfunction, and cardiovascular parameters.
|
|
|
|
|
|---|---|---|---|
| Real-Hohn et al., | Mitochondrial respiration | Increased O2 flux rate related to ATP production and greatest RCR values | Animal model (60 day-old Wistar rats, IF together with high intensity intermittent exercise for 8 weeks) |
| Castello et al., | ROS production | Reduced oxidative stress (improved the level of glutathione) and to decreased inflammatory status in the heart during aging | Animal model (2 months-old Sprague Dawley rats, alternate-day fasting until 6, 12, or 24 months) |
| Real-Hohn et al., | ROS production | a strong reduction in MDA levels in the IF/HIIE group; the IF/HIIE group presented lower levels of plasma protein oxidation. | Animal model (60 day-old Wistar rats, IF together with high intensity intermittent exercise for 8 weeks) |
| Ahmet et al., | Infarct size, cardiac remodeling | Reduction of the infarct size, cardiomyocyte apoptosis and infiltration with neutrophils and macrophages in rats subjected for experimental myocardial infarction; improvement of left ventricular (LV) remodeling and diastolic posterior wall thickness | Animal model (2 month-old Sprague-Dawley rats, alternate day fasting—every other day, 3 months) |
| Katare et al., | Infarct size, cardiac remodeling | Improvement of the rate survival after large myocardial infarction; activation of PI3kinase/Akt and VEGF pathway | Animal model (8-10 weeks-old Wistar rats; experimental myocardial infarction; after 2 week initiation of alternate day feeding until day 100 from onset of myocardial infarction) |
| Castello et al., | Interference with cytokine activity | Reduced the amount of TNFα, IL6, and IL1β in aged myocardium animals together with reduction of TGF-β1, collagen contents and NF-κB DNA binding activity | Animal model (2 months-old Sprague Dawley rats, alternate day fasting—every other day, for 6, 12, or 24 months) |
| Okoshi et al., | Cardiac remodeling | Reduction in total mortality after myocardial infarction; reduction of the left ventricular (LV) diastolic posterior wall thickness | Animal model (2 months-old Wistar rats, alternate day fasting—every other day, for 12 weeks, and subjected for myocardial infarction) |
| Basilio et al., | Glycemic control and cardiac remodeling, apoptosis | Improved glycemic values; reduction of cardiac interstitial collagen fraction; a low expression of proapoptotic gene BAX and of cytochrome C, and increased expression of the antiapoptotic protein Bcl-2 | Animal model (60 days-old Wistar rats, alternate day fasting—every other day, and exercise training, for 12 weeks) |
| Varady et al., | Lipid profile, cardiovascular risk | Improved lipid profile in obese patients | Human study [10-week trial in obese subjects, 3 phases: (1) a 2-week control phase, (2) a 4-week alternate day fasting controlled food intake phase, and (3) a 4-week alternate day fasting self-selected food intake phase] |
| Carvalho et al., | Cardiac remodeling, apoptosis | Reduction of collagen interstitial fraction, expression of proapoptotic gene BAX and of cytochrome C and increased expression of the antiapoptotic protein Bcl-2. | Animal model (60 day-old Wistar rats, alternate day fasting together with high intensity training for 12 weeks) |
| Hoddy et al., | Insulin-resistance and endothelial function | IF (alternate-day-fasting) reduce HOMA-IR in patients who are severely insulin resistant; no effects on endothelial function. | Human study (obese non-diabetic subjects, 8-week of alternate day fasting–25% energy intake “fast day”, alternated with |
| Bhutani et al., | Vascular relaxation (evaluated by brachial artery flow mediated dilation) | IF (alternate-day-fasting)—an effective intervention to improve vascular endothelial function (improved brachial artery flow mediated dilation in obese subjects) | Human study (obese subjects, 12 weeks of alternate day fasting— |
| Razzak et al., | Endothelium dependent relaxation | IF reduces weight of male rats and improves their aortic endothelium-dependent vasorelaxation | Animal model (Wistar rats, alternate day fasting for 2 months) |
| Headland et al., | Vascular relaxation (evaluated by brachial artery flow mediated dilation) | Two consecutive days of energy restriction (IF–5:2 diet) has no effect on endothelial function | Human study (4 weeks of low energy diet–500 calories for women, 600 calories for men, on two consecutive days per week and 5 days of habitual eating) |
Figure 1Main beneficial effects of caloric restriction (CR) and intermittent fasting (IF) dietary interventions on mitochondria, reactive oxygen species (ROS) production, and cardiovascular parameters.